Medicine and Dentistry
Thermal Burn
100%
Intensive Care Unit
100%
Retrospective Study
100%
Fenoldopam
100%
Low Drug Dose
77%
Acute Kidney Injury
44%
Systolic Blood Pressure
33%
Acute Renal Failure
33%
Drug Therapy
22%
Kidney Function
22%
Hypertensive Factor
22%
Creatinine
22%
Infusion Fluid
22%
Resuscitation
11%
Infusion
11%
Chi Square Test
11%
Randomized Controlled Trial
11%
Analysis of Variance
11%
Continuous Renal Replacement Therapy
11%
Fenoldopam Mesilate
11%
Dopamine 1 Receptor Stimulating Agent
11%
Keyphrases
Burn Intensive Care Unit
100%
Fenoldopam
100%
Acute Kidney Injury
30%
Systolic Blood Pressure
30%
Urine Output
30%
Burn Patients
20%
Medication Use
20%
Critically Ill
20%
Renal Function
20%
Serum Creatinine
20%
Intravenous Fluids
20%
Vasopressor Dependency Index
20%
Inotrope Score
20%
Resuscitation
10%
Severe Burns
10%
High Risk
10%
Receptor Agonist
10%
Highly Selective
10%
Consecutive Patients
10%
Retrospective Analysis
10%
Randomized Controlled Trial
10%
Dopamine D1 Receptor
10%
Fluid Restriction
10%
Chi-square Test
10%
One-way Analysis of Variance
10%
Hypertensive Crisis
10%
Sign Rank
10%
Intensive Care Unit Admission
10%
Continuous Renal Replacement Therapy
10%
Blood Pressure Increase
10%
Acute Kidney Injury Network
10%
Nursing and Health Professions
Burn Unit
100%
Fenoldopam
100%
Low Drug Dose
77%
Acute Kidney Failure
44%
Thermal Burn
33%
Urine Volume
33%
Systolic Blood Pressure
33%
Drug Therapy
22%
Infusion Fluid
22%
Hypertensive Factor
22%
Creatinine Blood Level
22%
Inotropic Agent
22%
Infusion
11%
Resuscitation
11%
Analysis of Variance
11%
Chi Square Test
11%
Dopamine 1 Receptor Stimulating Agent
11%
Continuous Renal Replacement Therapy
11%
Fenoldopam Mesilate
11%
Pharmacology, Toxicology and Pharmaceutical Science
Burn
100%
Retrospective Study
100%
Fenoldopam
100%
Acute Kidney Failure
44%
Hypertensive Factor
22%
Creatinine
22%
Infusion Fluid
22%
Inotropic Agent
22%
Replacement Therapy
11%
Randomized Controlled Trial
11%
Dopamine 1 Receptor Stimulating Agent
11%
Fenoldopam Mesilate
11%